NEVVI Medicare utilization intelligence
or

← back

Provider profile

PALMERI, MARTIN M.D.,M.B.A.

Hematology-Oncology · NPI 1811005374 · ASHEVILLE, NC

1
Groups
61
Codes · 2024
74,797
Disclosed services

PALMERI, MARTIN is a Hematology-Oncology in ASHEVILLE, NC, a member of 1 medical group, who billed 61 distinct codes to Medicare Part B in 2024.

Groups: AMERICAN ONCOLOGY PARTNERS PA (FORT WAYNE, IN)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

74,797
disclosed services
61
codes billed to Medicare Part B
Prior year · CY2023 63,669 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9299 Injection, nivolumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9271 Injection, pembrolizumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
J2469 Injection, palonosetron hcl, 25 mcg
J9041 Injection, bortezomib, 0.1 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
J0640 Injection, leucovorin calcium, per 50 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
J9196 Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9190 Injection, fluorouracil, 500 mg
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96372 Injection of drug or substance under skin or into muscle
96375 Injection of additional new drug or substance into vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
Q5130 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
J3489 Injection, zoledronic acid, 1 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96415 Administration of chemotherapy into vein, each additional hour
J7030 Infusion, normal saline solution , 1000 cc
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
81002 Urinalysis, manual test
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96523 Irrigation of implanted venous access drug delivery device
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96361 Infusion into a vein for hydration, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
96360 Infusion into a vein for hydration, 31-60 minutes
96411 Administration of additional new drug or substance into vein using push technique
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99195 Drawing of blood for a medical problem
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96374 Injection of drug or substance into vein
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
78816 Nuclear medicine study whole body with ct scan
71260 Ct scan of chest with contrast
85045 Red blood count, automated test
74177 Ct scan of abdomen and pelvis with contrast

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.